COVID, Cancer Care, and Cancer Research - National Coalition for Cancer Survivorship Cancer Policy Roundtable

Page created by Raymond Rice
 
CONTINUE READING
COVID, Cancer Care, and Cancer Research - National Coalition for Cancer Survivorship Cancer Policy Roundtable
COVID, Cancer Care, and
Cancer Research
National Coalition for Cancer Survivorship
Cancer Policy Roundtable

Norman E. Sharpless, M.D.
April 22, 2021                               @NCIDirector
                                               @TheNCI
COVID, Cancer Care, and Cancer Research - National Coalition for Cancer Survivorship Cancer Policy Roundtable
Today
• 50th Anniversary of the National Cancer Act
• Cancer Moonshot
• NCI Appropriations & Paylines
• COVID-19 Impacts and Activities
• NCI Activities in Cancer Survivorship
• Equity and Inclusion

                                                2
COVID, Cancer Care, and Cancer Research - National Coalition for Cancer Survivorship Cancer Policy Roundtable
“The President and I stand with you. This
is the fight of our lives, and we will never
stop working to end this disease. And
together, I know that we're going to go
farther than ever before.”
                                    Dr. Jill Biden
                              Virtual Visit to NCI
                               February 3, 2021

I’d love to be the President to preside
over the end of cancer as we know it.
These are the folks in the House and
Senate who would love to preside over
cancer —the end of cancer as we know it.
                            President Joe Biden
                           Bipartisan Meeting on
                             Cancer, Oval Office
                                   March 3, 2021
                                                     3
COVID, Cancer Care, and Cancer Research - National Coalition for Cancer Survivorship Cancer Policy Roundtable
What would it mean to end
 cancer as we know it?

   What would it take?

                            4
COVID, Cancer Care, and Cancer Research - National Coalition for Cancer Survivorship Cancer Policy Roundtable
National Cancer Act of 1971 50th Anniversary

  1971- 2021
COVID, Cancer Care, and Cancer Research - National Coalition for Cancer Survivorship Cancer Policy Roundtable
Cancer MoonshotSM

                    6
COVID, Cancer Care, and Cancer Research - National Coalition for Cancer Survivorship Cancer Policy Roundtable
Select Cancer Moonshot efforts in survivorship
Initiative                    Grants / Projects                             Principal Investigator
Improving the Management of   A Randomized Trial of a Mobile Health and     Nina S. Kadan-Lottick,
symPtoms during and           Social Media Physical Activity Intervention   Jason A. Mendoza
following Cancer Treatment    Among Adolescent and Young Adult
(IMPACT)                      Childhood Cancer Survivors
Improving Outcomes for        Self-Management to Optimize Survivorship      Virginia Chih-Yi Sun
Pediatric, Adolescent and     Care and Outcomes in Lung and Colorectal
Young Adult (AYA) Cancer      Cancer
Survivors
Optimizing the Management     The EPICS (Engaging Primary Care In           Erin Elizabeth Hahn
and Outcomes for Cancer       Cancer Survivorship) Study: A Randomized
Survivors Transitioning to    Trial of Novel Models of Care for Cancer
Follow-up Care                Survivors

                              Optimizing Functional Outcomes of Older       Supriya G. Mohile, Michelle
                              Survivors After Chemotherapy                  C. Janelsins, Karen M.
                                                                            Mustian

                                                                                                          7
COVID, Cancer Care, and Cancer Research - National Coalition for Cancer Survivorship Cancer Policy Roundtable
NCI Appropriations                                   21st Century Cures Act - orange
FY 2015 – 2021 (in millions)                      Childhood Cancer Initiative - green

                                                                                 $6,560
  $7,000                                                         $6,440
                                         $5,965        $6,144     $195
                                                                                  $195
                                                                           $50             $50
  $6,000                       $5,689                   $400
                                          $300                   $6,195          $6,315
                                $300
                                         $5,665        $5,744
  $5,000                       $5,389
                     $5,215
           $4,950
  $4,000
                                                                 + $306M
                                                                 COVID-19
  $3,000                                                         serology
                                                                 (April 2020)

  $2,000

  $1,000

     $0
           FY 2015   FY 2016   FY 2017   FY 2018       FY 2019   FY 2020         FY 2021
                                                                                                 8
COVID, Cancer Care, and Cancer Research - National Coalition for Cancer Survivorship Cancer Policy Roundtable
NCI Paylines for FY 2021
     GRANT TYPE                  PAYLINE
      R01 Grants for                            15 by 25
   Established and New        11th Percentile
       Investigators                              goal
   R01 Grants for Early-
 Stage Investigators (ESIs)
                              16th Percentile      15th
                                                 percentile
  R21 Exploratory Grants      9th Percentile
                                                R01 payline
 Non-competing grants will be funded at 100%.
                                                  by 2025

                                                              9
COVID, Cancer Care, and Cancer Research - National Coalition for Cancer Survivorship Cancer Policy Roundtable
NCI COVID-19 activities
F O U N D AT I O N A L   CLINICAL &                               SUPPORT FOR CANCER
SEROLOGY                 T R A N S L AT I O N A L                 RESEARCH AND CARE
                                                                  A M I D T H E PA N D E M I C
                         SEROLOGY
Serological Sciences                                              NCI COVID-19 in Cancer
                         Sero-protection Studies:
Network (SeroNet)        •   Mount Sinai, University of Arizona   Patients Study (NCCAPS)
                         •   NIH All of Us                        Flexibilities for grantees
• 8 Centers of           •   NCI SEER + Health Verity
  Excellence                                                      Clinical trials adaptations
                         COVID-19 Seroprevalence Studies          Modeling to predict long-term
• 13 Research Projects
                         Hub (SeroHub)                            cancer outcomes
• 4 Capacity Building
  Centers                Antibody test performance
                         evaluation, with FDA                     ADDITIONAL COVID-19
• FNL Serology Lab &
  Network Coordinating   Standard reference serum                 RESEARCH
  Center                                                          • Excess Mortality Study
                         Clinical trials for COVID-19
                         therapeutics                             • Digital Health
                              • Tocilizumab                         Solutions (with NIBIB)
                              • CD24Fc                            • ACTIV (trans-NIH)

                                                                                                  10
NCI COVID-19 in Cancer Patients Study (NCCAPS)

 900+           Special emphasis on
                      minority,
                                             Enrolled
                                            patients will
 TRIAL SITES      underserved and           be followed
 ACTIVATED
     IN
                 rural communities          for 2 years
                                                            1051
    50           Now open to pediatric
                      patients            Aims to enroll
                                                              PATIENTS
                                                             ENROLLED
    STATES                                2,000 patients
 + DC, PUERTO     Launched May 21         across 1,000
   RICO, AND    Conception to Launch in    sites in U.S.
    CANADA            6 weeks

                                                            As of April 19, 2021.   11
COVID-19 & Cancer

                    time.com AUGUST 28, 2020   12
Impact of COVID-19 Pandemic on Cancer Screening in the US
     Colorectal Cancer Screening                      Lung Cancer Screening
       (Colonoscopy and FIT)                                 (LDCT)

                           Cancer Screening During the Coronavirus Disease-2019 Pandemic: A
                          Perspective From the National Cancer Institute’s PROSPR Consortium.
                                             Gastroenterology, Volume 160, Issue 4, 999 - 1002   13
Impact of COVID-19 Pandemic on Cancer Screening in the US
       Cervical Cancer Screening                           Breast Cancer Screening
              (Pap Smear)                                      (Mammography)

                            Cancer Screening During the Coronavirus Disease-2019 Pandemic: A
                                      Perspective From the National Cancer Institute’s PROSPR
                                 Consortium. Gastroenterology, Volume 160, Issue 4, 999 - 1002   14
Centers on Telehealth Research for Cancer-Related
Care – Goals:
               Leverage the P50 mechanism to:
               1. Create national centers for advancing
   RFA            cancer-related telehealth research in a
 CA-21-029        rapidly changing environment
               2. Establish a robust evidence base for
                  patient-centered, sustainable telehealth
                  models of cancer care delivery
               3. Foster the development, evaluation, and
                  dissemination of evidence-based models of
                  cancer-focused telehealth
                                                              15
Emily S. Tonorezos, MD, MPH
            Director
 Office of Cancer Survivorship
Division of Cancer Control and
      Population Sciences

                                 16
STAR Act Implementation
                                                                          Identifying best
    New survivorship                   New biobanking
                                                                            practices in
 research opportunities                   projects
                                                                         survivorship care
• Improving Outcomes for          • Several Children’s               • Partnership with the Agency
  Pediatric, Adolescent and         Oncology Group projects,           for Healthcare Research and
  Young Adult Cancer                including the Rare Tumor           Quality (AHRQ)
  Survivors: 7 U01 awards           Populations Biobank
                                                                     • 1st of 3 evidence reviews
• Research to Reduce
                                  • Projects in collaboration with     published in March 2021
  Morbidity and Improve Care
                                    the Childhood Cancer               focused on Disparities and
  for Pediatric, and Adolescent
                                    Survivor Study                     Barriers to Pediatric Cancer
  and Young Adult (AYA)
                                                                       Survivorship Care
  Cancer Survivors
                                  • Specimen collection efforts in
                                                                     • 2 reviews in progress, to be
                                    collaboration with the             published later this year,
                                    Childhood Cancer Data
                                                                       focusing on models of care
                                    Initiative                         and transitions in care

                                                                                                      17
4/23/21
NCI Equity and Inclusion Program
EQUITY               Chair                   Mark Alexander        Montse Garcia-        Donna Siegle
                     Ned Sharpless           Andrea Apolo          Closas                Dinah Singer
COUNCIL
                                             Nelvis Castro         Anne Lubenow          Sanya Springfield
                     Vice Chair              Bob Croyle            Ji Luo
                     Paulette Gray

WORKING GROUP 1      WORKING GROUP 2         WORKING GROUP 3       WORKING GROUP 4       WORKING GROUP 5
Enhancing            Ensuring Diversity of   Promoting an          Systematic Tracking   Communications
Research to          Thought and             Inclusive and         and Evaluation of     and Outreach for
Address Cancer       Background in the       Equitable Community   Equity Activities     Equity Activities
Health Disparities   Cancer Research         at NCI
                     Workforce

CO-CHAIRS            CO-CHAIRS               CO-CHAIRS             CO-CHAIRS             CO-CHAIRS
Jim Doroshow         LeeAnn Bailey           Shannon Bell          Michelle Bennett      Peter Garrett
Worta McCaskill-     Susan McCarthy          Paige Green           Doug Lowy             Angela Jones
Stevens              Glenn Merlino           Satish Gopal                                Anita Linde
Tiffany Wallace

                                                                                                             19
Discussion
You can also read